Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Published Online: 2018-04-30
Journal: Nature MedicineLoading...
Authors: Alexander C. Huang•Alina C. Boesteanu•Bruce L. Levine•Carl H. June•Changfeng Zhang•Corin Dorfmeier•David E. Ambrose•David L. Porter•Donald L. Siegel•E. John Wherry•Edward Pequignot•Elena J. Orlando•F. Brad Johnson•Fang Chen•Felipe Bedoya•Hans Bitter•Harit Parakandi•Irina Kulikovskaya•Iulian Pruteanu-Malinici•J. Joseph Melenhorst•Jennifer L. Brogdon•Joseph A. Fraietta•Jun Xu•Li Liu•Lifeng Tian•Megan M. Davis•Mercy Gohil•Minnal Gupta•Nicholas Wilcox•Noelle V. Frey•Regina M. Young•Roddy S. O’Connor•Sadik H. Kassim•Simon F. Lacey•Stefan Lundh•Wei-Ting Hwang•Yan Wang
